Home
Pharmaceutical Portfolio & Lifecycle Management
17 April - 18 April 2013
Pharmaceutical Portfolio & Lifecycle Management

R&D prices are skyrocketing ever higher, whilst the drug development industry feels the squeeze of the recession. With this ever-increasing need to ensure a cost-effective and efficient portfolio, the planning and preparation for each drug portfolio must be optimised to provide the maximum revenue for the minimum expenditure.

Expert speakers will explore and debate the key success factors for portfolio planning and lifecycle management, including risk assessment, effective decision making, market exclusivity and innovation of products in pharma.

This is the 8th conference in this winning annual series and we are certain it will be the best yet! With 20 expert speakers, 17 in-depth presentations and two interactive half-day workshops this will be the one conference in 2013 to attend for the very latest intelligence to help you develop winning strategies in an increasingly challenging marketplace.

FEATURED SPEAKERS

Kimber Hardy

Kimber Hardy

Head of Valuation and Analysis, Portfolio Management , Merck Serono International S.A.
Lucette  Doessegger

Lucette Doessegger

Safety Risk Management/Global Head of Licensing and Early Development, F. Hoffmann La-Roche AG
Richard Fazackerley

Richard Fazackerley

Director - Global Demand Chain Technology , Eisai
Tom Halliwell

Tom Halliwell

Associate Director, Programme Management, Norgine Ltd

Bruce Sunstein

Attorneys at Law, Sunstein Kann Murphy & Timbers LLP
Bruce Sunstein

Christopher Maierhöfer

Attorney-at-law, Bird & Bird LLP
Christopher Maierhöfer

Florian Jehle

Principal, Catenion
Florian  Jehle

Gerhard Gross

Director, Early Drug Developability, Janssen Research and Development
Gerhard Gross

Harry Kraft

Senior Patent Attorney , Ablynx
Harry  Kraft

Howard Stevens

Assistant Head of Institute and Professor of Drug Delivery, University of Strathclyde
Howard Stevens

Joachim Greuel

Adjunct Professor of Finance & Healthcare Management, IE Business School
Joachim Greuel

John Ansell

Director, John Ansell Consultancy
John Ansell

Kimber Hardy

Head of Valuation and Analysis, Portfolio Management , Merck Serono International S.A.
Kimber Hardy

Lucette Doessegger

Safety Risk Management/Global Head of Licensing and Early Development, F. Hoffmann La-Roche AG
Lucette  Doessegger

Pankaj Oza

Principal consultant, IDEA Pharma UK
Pankaj Oza

Richard Fazackerley

Director - Global Demand Chain Technology , Eisai
Richard Fazackerley

Roger Holdsworth

European Business Development Lead, Kromite
Roger  Holdsworth

Tim Harris

Managing Director (former Senior Director at GSK), Turnstone Business Solutions Ltd.
Tim Harris

Tom Halliwell

Associate Director, Programme Management, Norgine Ltd
Tom Halliwell

Tony Ellery

CEO, Ellery Pharma Consulting
Tony Ellery

Tony Ellery

Former Global Head of Lifecycle Management in Portfolio Management, Novartis, Ellery Pharma Consulting
Tony Ellery

Vladimir Anisimov

Honorary Professor in the School of Mathematics and Statistics, University Of Glasgow
Vladimir Anisimov

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Tony Ellery

Tony Ellery, CEO, Ellery Pharma Consulting

clock

9:10

Chain strategy for portfolio management/LCM

Richard Fazackerley

Richard Fazackerley, Director - Global Demand Chain Technology , Eisai

  • Designing products for a cost effective & efficient launch
  • Lifecycle management of the supply chain
  • Considerations for establishing a robust, reliable & flexible global supply chain
  • Product design to facilitate market access & LCM
  • clock

    9:50

    Concept of safety medicine

    Lucette  Doessegger

    Lucette Doessegger, Safety Risk Management/Global Head of Licensing and Early Development, F. Hoffmann La-Roche AG

  • Concept of Translational Safety Medicine
  • Approaches to integrated safety sciences
  • Implications of pre-clinical findings to human and pitfalls
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Predictive analytic modelling different stages of drug development

    Vladimir Anisimov

    Vladimir Anisimov, Honorary Professor in the School of Mathematics and Statistics, University Of Glasgow

  • Main uncertainties and risks in design of late stage clinical trials
  • Analytic data-driven technique for predictive patient recruitment modelling
  • Predicting trial performance and site productivity
  • Analysis of randomization schemes and impact on statistical design and supply chain process
  • Risk-based analytic supply chain modelling
  • Quantitative analysis of different stages of drug development
  •  

    clock

    11:40

    Portfolio management for early stage assets

    Florian  Jehle

    Florian Jehle, Principal, Catenion

  • Context for R&D Decision Making
  • Project Level decision making for Early Stage Assets
  • Portfolio level decision making
     
  • clock

    12:20

    Networking Lunch

    clock

    13:30

    How and why product potential is underestimated

    John Ansell

    John Ansell, Director, John Ansell Consultancy

  • Examples of underestimation
  • Why underestimation rather than overestimation?
  • Planning to maximise commercial potential
  • clock

    14:10

    Enhancing readout from Phase I studies and MIST guidance

    Gerhard Gross

    Gerhard Gross, Director, Early Drug Developability, Janssen Research and Development

  • Regulatory environment for metabolites and safety of metabolites
  • Lundbeck's MIST strategy
  • Obtaining early information on human metabolites
  • Human metabolite exposure: New models in area
  • clock

    14:50

    Afternoon Tea

    clock

    15:20

    The drug delivery contribution to life cycle management

    Howard Stevens

    Howard Stevens, Assistant Head of Institute and Professor of Drug Delivery, University of Strathclyde

  • New presentations of 'old' drugs vs 'new' drugs
  • Working with academics
  • The marketing impact of imaging in-vivo performance
  • Emerging drug delivery opportunities
     

     

  • clock

    16:00

    Proving the value of innovation: Lifecycle begins in phase II

    Pankaj Oza

    Pankaj Oza, Principal consultant, IDEA Pharma UK

  • Designing path-to-market based on what customers want
  • Gateways, bridges, high road, low roads: indication sequencing
  • Indications are not destinations; portfolios half empty or half full
  • Where is the strategy in the strategy: what should portfolio strategy mean?

     

  • clock

    16:40

    Current and cutting edge methods for strategic portfolio management in pharmaceuticals

    Roger  Holdsworth

    Roger Holdsworth, European Business Development Lead, Kromite

  • Factors influencing decision making in the internal and external environment
  • Decisive data - what do we need to take account of?
  • Multiple Objective Decision Analysis - an effective method for multifactorial analysis
  • Application to portfolio optimisation
  • clock

    17:20

    Chairman's Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Howard Stevens

    Howard Stevens, Assistant Head of Institute and Professor of Drug Delivery, University of Strathclyde

    clock

    9:10

    Managing portfolio risks

    Kimber Hardy

    Kimber Hardy, Head of Valuation and Analysis, Portfolio Management , Merck Serono International S.A.

  • Types of Portfolio Risk. Acceptable levels of Pipeline Risk
  • The "Flaw of Averages". Uses of Monte Carlo Simulation. Ranges
  • Commercial and Technical Risks. Correlated risks in portfolios
  • Presenting Portfolio Risks: Decision-Making and Risk Management
  • clock

    9:50

    Is there a role for innovation in Project/Programme Management?

    Tom Halliwell

    Tom Halliwell, Associate Director, Programme Management, Norgine Ltd

  • What is the point of Innovation?
  • Which areas need innovation?
  • How can innovation be focused?

     

  • clock

    10:30

    Morning Coffee

    clock

    11:00

    The role of financial modeling in pharmaceutical portfolio management

    Joachim Greuel

    Joachim Greuel, Adjunct Professor of Finance & Healthcare Management, IE Business School

    clock

    11:40

    Putting portfolio risks into perspective

    Tim Harris

    Tim Harris, Managing Director (former Senior Director at GSK), Turnstone Business Solutions Ltd.

  • The types of risks to your portfolio
  • Why do the risks matter?
  • The importance of context
  • Strategies to manage the risks

     

  • clock

    12:20

    Networking Lunch

    clock

    13:30

    Patent enforcement in Europe - recent developments

    Christopher Maierhöfer

    Christopher Maierhöfer, Attorney-at-law, Bird & Bird LLP

  • The current landscape in Europe
  • Ways to a patent with unitary protection
  • Trends in pharmaceuticals

     

  • clock

    14:10

    Sustainability of brand lifecycle management

    Tony Ellery

    Tony Ellery, CEO, Ellery Pharma Consulting

  • Challenges facing LCM in 2013 and beyond
  • Sustainable and non-sustainable LCM strategies
  • Creating an Integrated LCM Plan
     
  • clock

    14:50

    Afternoon Tea

    clock

    15:20

    Building an IP portfolio for making deals

    Harry  Kraft

    Harry Kraft, Senior Patent Attorney , Ablynx

  • Platform IP versus project IP
  • Who looks at biotech IP, when and why
  • Difference between biotech IP and big pharma IP
  • Combining patents and know-how into an integrated IP strategy
  • Building and maintaining an IP portfolio for making deals 
  • clock

    16:00

    Patenting drugs and challenging drug patents under the new U.S. patent law

    Bruce Sunstein

    Bruce Sunstein, Attorneys at Law, Sunstein Kann Murphy & Timbers LLP

  • Strategies for dealing with expanded scope of prior art in the U.S.
  • Inter partes review procedure
  • The new post grant review procedure
  • clock

    16:40

    Chairman’s Closing Remarks and Close of Day Two


    CEO
    Ellery Pharma Consulting
    Director - Global Demand Chain Technology
    Eisai
    Associate Director, Programme Management
    Norgine Ltd
    Adjunct Professor of Finance & Healthcare Management
    IE Business School
    Managing Director (former Senior Director at GSK)
    Turnstone Business Solutions Ltd.
    Attorney-at-law
    Bird & Bird LLP
    Senior Patent Attorney
    Ablynx
    Attorneys at Law
    Sunstein Kann Murphy & Timbers LLP
    European Business Development Lead
    Kromite
    Safety Risk Management/Global Head of Licensing and Early Development
    F. Hoffmann La-Roche AG
    Honorary Professor in the School of Mathematics and Statistics
    University Of Glasgow
    Principal
    Catenion
    Director
    John Ansell Consultancy
    Director, Early Drug Developability
    Janssen Research and Development
    Assistant Head of Institute and Professor of Drug Delivery
    University of Strathclyde
    Principal consultant
    IDEA Pharma UK
    Head of Valuation and Analysis, Portfolio Management
    Merck Serono International S.A.
    Former Global Head of Lifecycle Management in Portfolio Management, Novartis
    Ellery Pharma Consulting

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.